An efficacy and safety study of certolizumab pegol (CP) in patients with Crohn's disease
Latest Information Update: 02 Jul 2019
At a glance
- Drugs Certolizumab pegol (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 02 Jul 2019 New trial record